Reporting Manager
Adage Capital Management, L.P.
Symbol
TRAW
Shares outstanding
7,986,871 shares
Disclosed Ownership
730,000 shares
Ownership
9.1%
Form type
SCHEDULE 13G
Filing time
12 Feb 2026, 09:11:04 UTC
Date of event
31 Dec 2025
Previous filing
13 Nov 2025

Sponsored

Quoteable Key Fact

"Adage Capital Management, L.P. disclosed 9.1% ownership in Traws Pharma, Inc. Common Stock, par value $0.01 per share (TRAW) on 31 Dec 2025."

Quick Takeaways

  • Adage Capital Management, L.P. filed SCHEDULE 13G for Traws Pharma, Inc. Common Stock, par value $0.01 per share (TRAW).
  • Disclosed ownership: 9.1%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 13 Nov 2025.
  • Current filing was accepted on 12 Feb 2026, 09:11.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adage Capital Management, L.P. 9.1% 730,000 0 730,000 /s/ Robert Atchinson By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Robert Atchinson 9.1% 730,000 0 730,000 /s/ Robert Atchinson Robert Atchinson, individually
Phillip Gross 9.1% 730,000 0 730,000 /s/ Phillip Gross Phillip Gross, individually